Skip to main content
Top
Published in: Intensive Care Medicine 3/2010

01-03-2010 | Editorial

Biomarkers and acute kidney injury: dining with the Fisher King?

Authors: Catherine S. C. Bouman, Lui G. Forni, Michael Joannidis

Published in: Intensive Care Medicine | Issue 3/2010

Login to get access

Excerpt

Despite its limited utility, the serum creatinine remains an essential part of both the RIFLE and AKIN criteria for the diagnosis of acute kidney injury (AKI) [1]. Due to the delayed rise in creatinine following injury, nephrologists and intensivists alike continue to search for the holy grail of AKI: an early and reliable biomarker of kidney injury. Biomarkers are biological parameters that may indicate normal or pathological processes or responses to interventions and may be objectively quantified. The sensitivity, specificity and time course of a biomarker are critical factors in determining its use in any disease process. But more importantly, the utility of a biomarker depends on the purpose it is expected to fulfill. Summarzing current literature, it appears that an ideal biomarker for AKI should fulfill the following criteria:
  • It should distinguish pre-renal AKI from apoptotic and necrotic injury
  • It should be specific for renal injury in the presence of concomitant injury involving other organs
  • It should allow timing of the onset or stage of injury
  • It should predict outcome
  • In the end it should act as surrogate end point useful for clincial interventional studies
Literature
1.
go back to reference Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMed Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMed
2.
go back to reference Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D′amico G, Goldsmith D, Devarajan P, Bellomo R (2009) Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. doi:10.1007/s00134-009-1724-9 Bagshaw SM, Bennett M, Haase M, Haase-Fielitz A, Egi M, Morimatsu H, D′amico G, Goldsmith D, Devarajan P, Bellomo R (2009) Plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. doi:10.​1007/​s00134-009-1724-9
3.
go back to reference Cruz DN, De Cal M, Garzotto F, Perazella M, Lentini P, Corradi V, Piccini P, Ronco C (2009) Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. doi:10.1007/s00134-009-1711-1 Cruz DN, De Cal M, Garzotto F, Perazella M, Lentini P, Corradi V, Piccini P, Ronco C (2009) Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med. doi:10.​1007/​s00134-009-1711-1
4.
go back to reference Kümpers P, Hafer C, Sascha D, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein J, Faulhaber-Walter R (2009) Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction, and outcome. Intensive Care Med. doi:10.1007/s00134-009-1726-7 Kümpers P, Hafer C, Sascha D, Hecker H, Lukasz A, Fliser D, Haller H, Kielstein J, Faulhaber-Walter R (2009) Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction, and outcome. Intensive Care Med. doi:10.​1007/​s00134-009-1726-7
5.
go back to reference Coca SG, Yalavarthy R, Concato J, Parikh CR (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73:1008–1016CrossRefPubMed Coca SG, Yalavarthy R, Concato J, Parikh CR (2008) Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73:1008–1016CrossRefPubMed
6.
go back to reference Endre ZH, Westhuyzen J (2008) Early detection of acute kidney injury: emerging new biomarkers. Nephrology (Carlton) 13:91–98CrossRef Endre ZH, Westhuyzen J (2008) Early detection of acute kidney injury: emerging new biomarkers. Nephrology (Carlton) 13:91–98CrossRef
7.
go back to reference Soni SS, Ronco C, Katz N, Cruz DN (2009) Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif 28:165–174CrossRefPubMed Soni SS, Ronco C, Katz N, Cruz DN (2009) Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif 28:165–174CrossRefPubMed
8.
go back to reference Cowland JB, Borregaard N (1997) Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45:17–23CrossRefPubMed Cowland JB, Borregaard N (1997) Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45:17–23CrossRefPubMed
9.
go back to reference Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543CrossRefPubMed Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543CrossRefPubMed
10.
go back to reference Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. doi:10.1053/j.ajkd.2009.07.020 Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. doi:10.​1053/​j.​ajkd.​2009.​07.​020
11.
go back to reference Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR (2008) Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 36:1297–1303CrossRefPubMed Wheeler DS, Devarajan P, Ma Q, Harmon K, Monaco M, Cvijanovich N, Wong HR (2008) Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 36:1297–1303CrossRefPubMed
12.
go back to reference Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KG, Wickersham N, Bossert F, Ikizler TA (2009) Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 20:1823–1832CrossRefPubMed Siew ED, Ware LB, Gebretsadik T, Shintani A, Moons KG, Wickersham N, Bossert F, Ikizler TA (2009) Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol 20:1823–1832CrossRefPubMed
13.
go back to reference van Meurs M, Kurniati NF, Wulfert FM, Asgeirsdottir SA, Satchell SC, de GI, Mathieson PW, Jongman RM, Kümpers P, Zijlstra JG, Heeringa P, Molema G (2009) Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am J Physiol Renal Physiol. 297:F272–F281CrossRefPubMed van Meurs M, Kurniati NF, Wulfert FM, Asgeirsdottir SA, Satchell SC, de GI, Mathieson PW, Jongman RM, Kümpers P, Zijlstra JG, Heeringa P, Molema G (2009) Shock-induced stress induces loss of microvascular endothelial Tie2 in the kidney which is not associated with reduced glomerular barrier function. Am J Physiol Renal Physiol. 297:F272–F281CrossRefPubMed
14.
go back to reference Kümpers P, Van MM, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG (2009) Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care. 13:R64CrossRefPubMed Kümpers P, Van MM, David S, Molema G, Bijzet J, Lukasz A, Biertz F, Haller H, Zijlstra JG (2009) Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis. Crit Care. 13:R64CrossRefPubMed
15.
go back to reference Wagner JA, Williams SA, Webster CJ (2007) Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther 81:104–107CrossRefPubMed Wagner JA, Williams SA, Webster CJ (2007) Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther 81:104–107CrossRefPubMed
16.
go back to reference Waikar SS, Betensky RA, Bonventre JV (2007) Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 24:3263–3265CrossRef Waikar SS, Betensky RA, Bonventre JV (2007) Creatinine as the gold standard for kidney injury biomarker studies? Nephrol Dial Transplant 24:3263–3265CrossRef
Metadata
Title
Biomarkers and acute kidney injury: dining with the Fisher King?
Authors
Catherine S. C. Bouman
Lui G. Forni
Michael Joannidis
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 3/2010
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-009-1733-8

Other articles of this Issue 3/2010

Intensive Care Medicine 3/2010 Go to the issue